VEGFA and proliferative diabetic retinopathy: Prior studies have compared ocular inflammation in patients treated with intravitreal anti-VEGF for various exudative eye diseases (e.g., non-proliferative diabetic retinopathy, macular edema with branch or central retinal vein occlusion).